Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi-Aventis Expands Rimonabant Diabetes Program With Multiple Trials

Related Content

Januvia Clears FDA; Sitagliptin Has “Neutral Effects” On Weight, Agency Says

Oct 23 2006

Zimulti Loses On Weight Loss; Sanofi May Try Diabetes Route To Get Approval

Jun 18 2007

Sanofi Seeks Further FDA Input Following Zimulti NDA Withdrawal

Jul 02 2007

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window